Moderna Stock Had A Readout Waiting In Plain Sight
Yahoo Finance · Aug 24, 2026 · Sarepta Therapeutics Inc (SRPT)
Before the melanoma result, the visible signs were an enrolled trial, a partner paying half its cost, and a market that had stopped pricing an unusually large move.
Not investment advice. Cached headline, not a full reprint.